FREE Webinar:
Recent Advances in the
Treatment of Bipolar Disorder
March 28th, 2022
Monday
17:00
GMT
Free
Registration is required
Certification
To all attendants via email
“Recent Advances in the Treatment of Bipolar Disorder”
March 28th, 2022 at 17:00 GMT
New York
13:00
London
18:00
Athens
20:00
San Diego
10:00
Paris, Rome
19:00
Beijing
01:00 (29/03)
Bipolar disorder is a mental disorder characterized by relapsing episodes of mania/hypomania and depression which often develop eventually into chronic bipolar depression.
Typically the onset is during young adulthood, and many patients spend prolonged periods of time diagnosed as suffering from unipolar depression before eventually the first manic episode appears. Psychotic symptoms are not uncommon as well as cognitive impairment and significant disability. A significant proportion of patients will never recover completely and repeated hospitalizations or life-long protective living might be necessary for some.
Social problems such as long-term unemployment, poverty, homelessness, exploitation, and victimization as well as problems with the law are commonly correlated with bipolar disorder, and especially with its non-classic forms. The treatment is maybe the most complex and demanding among mental disorders and it includes medication, along with psychotherapy, counseling and social rehabilitation.
The WPA webinars on Bipolar disorder clinical management will be addressed mainly to the clinical doctors, who would like to enrich their practical experience in the treatment of Bipolar disorders in order to bring our patients back to their families and even to their job.
The Webinar is organized for mental health professionals by the World Psychiatric Association
During the upcoming webinar you will have a unique opportunity not just to listen to the experts, but also to discuss your questions during Q&A sessions.
SPEAKERS
Prof. Mauricio Tohen
"Management of Acute Mania"
Mauricio Tohen, MD, DrPH, MBA is the Chairman of the Department of Psychiatry & Behavioral Sciences and University Distinguished Professor at the U of New Mexico Health Sciences Center in Albuquerque NM, USA. His areas of expertise include Treatment and Outcome in Bipolar Disorder and First Episode Psychosis.
He has authored over 350 original publications and has over 35,000 scientific citations. In 2014, Dr. Tohen was recognized in Thomson Reuter’s “The World’s Most Influential Scientific Minds, 2014”. Honorees were the scientists who ranked in the top 1 percent by citations of their published work in 21 broad fields between 2002 and 2012. Dr. Tohen is one of 100 scientists worldwide recognized in the Psychiatry/psychology category.
In 2016 the International Society for Bipolar disorders awarded him the Mogens Schou award for Education and Teaching. Dr. Tohen was selected as a 2016 NAMI Exemplary Psychiatrist. In 2017, Dr Tohen was recognized in expertscape as Top 0.12% Expertise in Bipolar Disorder Worldwide based in published articles from 2007-2017 and 2010-2020
Prof. Alan Young
"Long term treatment of Bipolar Disorder"
Professor Allan Young is Chair of Mood Disorders and Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, where he is also Head of School and Vice-Dean for Academic Psychiatry. Professor Young is the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) Cluster and Theme Lead in the Translational Therapeutics Cluster. He is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust, where he is also Consultant Psychiatrist and Head of the Affective Disorders Service.
Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders. He has received research grants from several funding agencies and has over 500 peer-reviewed publications, including several books about psychopharmacology and affective disorders.
He is immediate past President of the International Society for Affective Disorders, past President of the British Association of Psychopharmacology and immediate past Chair of the Special Committee for Psychopharmacology of the Royal College of Psychiatrists. He is also a trustee of the patient and family charity Bipolar UK, and of the Drug Safety Research Unit (DSRU), internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.
Professor Young is a Clarivate Highly Cited Researcher 2020
Organization
